Alimera Sciences Net debt/EBITDA
Qual é o Net debt/EBITDA de Alimera Sciences?
O Net debt/EBITDA de Alimera Sciences Inc. é -46.51
Qual é a definição de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA de empresas na Setor Health Care em NASDAQ em comparação com Alimera Sciences
O que Alimera Sciences faz?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Empresas com net debt/ebitda semelhantes a Alimera Sciences
- Inca One Gold tem Net debt/EBITDA de -47.04
- Journeo plc tem Net debt/EBITDA de -46.99
- McBride Plc tem Net debt/EBITDA de -46.99
- Raise Production tem Net debt/EBITDA de -46.96
- Summer Infant Inc tem Net debt/EBITDA de -46.90
- Majestic Wine Plc tem Net debt/EBITDA de -46.57
- Alimera Sciences tem Net debt/EBITDA de -46.51
- Husky tem Net debt/EBITDA de -46.47
- Hydoo International tem Net debt/EBITDA de -46.45
- Partner Jet tem Net debt/EBITDA de -46.32
- China Wan Tong Yuan () tem Net debt/EBITDA de -46.19
- Trafalgar Property plc tem Net debt/EBITDA de -46.15
- Astronics tem Net debt/EBITDA de -46.11